The oncogenic functions of these YAP1 fusions fundamentally rely on their ability to exert deregulated YAP activity, and YAP1 fusion-positive human meningiomas resemble NF2 mutant meningiomas by both gene expression and DNA methylation-based classification (13–15, 23). The gene discussed is YAP1; the disease is meningioma.